These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30406984)

  • 1. Recent Advances in Chromatography for Pharmaceutical Analysis.
    D'Atri V; Fekete S; Clarke A; Veuthey JL; Guillarme D
    Anal Chem; 2019 Jan; 91(1):210-239. PubMed ID: 30406984
    [No Abstract]   [Full Text] [Related]  

  • 2. Selection of internal standard for quantitative analysis of enantiomers following precolumn chiral derivatization.
    Srinivas NR
    J Chromatogr B Biomed Sci Appl; 1998 May; 709(2):321-3. PubMed ID: 9657232
    [No Abstract]   [Full Text] [Related]  

  • 3. Uniformly sized molecularly imprinted polymers: their applications to chiral separation and bioanalysis.
    Haginaka J; Sanbe H
    Se Pu; 2004 Jul; 22(4):306-8. PubMed ID: 15709395
    [No Abstract]   [Full Text] [Related]  

  • 4. Determination of d-alpha-tocopherol and its impurity by chiral high performance liquid chromatography in pharmaceutical preparations.
    Kłaczkow G; Jakoniuk D; Anuszewska EL
    Acta Pol Pharm; 2004; 61(3):181-4. PubMed ID: 15481242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent applications of polysaccharide-type chiral stationary phases for the enantioselective analysis of chiral drugs with one and two stereogenic centers.
    Aboul-Enein HY
    Biomed Chromatogr; 1998; 12(3):116-9. PubMed ID: 9646904
    [No Abstract]   [Full Text] [Related]  

  • 6. Improving sensitivity in chiral supercritical fluid chromatography for analysis of active pharmaceutical ingredients.
    Helmy R; Biba M; Zang J; Mao B; Fogelman K; Vlachos V; Hosek P; Welch CJ
    Chirality; 2007 Nov; 19(10):787-92. PubMed ID: 17722016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Resolution of enantiomers and diastereoisomers by HPLC and its application in pharmaceutica analysis].
    Lu XL; Yang XK
    Yao Xue Xue Bao; 1987 Oct; 22(10):790-800. PubMed ID: 3329803
    [No Abstract]   [Full Text] [Related]  

  • 8. Finding key impurities in different manufacturing routes of a drug substance using liquid chromatography/mass spectrometry followed by principal components analysis.
    Carrier D; Eckers C; Arnoult T; Thurston T; Major H
    Rapid Commun Mass Spectrom; 2007; 21(23):3946-8. PubMed ID: 17975854
    [No Abstract]   [Full Text] [Related]  

  • 9. Application of capillary electrophoresis to pharmaceutical analysis.
    Altria KD
    Methods Mol Biol; 1996; 52():265-84. PubMed ID: 8746691
    [No Abstract]   [Full Text] [Related]  

  • 10. Liquid chromatographic/mass spectrometric determination of optically active drugs.
    Crowther JB; Covey TR; Dewey EA; Henion JD
    Anal Chem; 1984 Dec; 56(14):2921-6. PubMed ID: 6524665
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioanalytical derivatization: is there still room for development?
    Giera M
    Bioanalysis; 2015 Oct; 7(19):2439-41. PubMed ID: 26457481
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative analysis of drugs in biological matrices by HPLC hyphenated to fluorescence detection.
    Lipka E; Vaccher C
    Bioanalysis; 2015; 7(6):743-62. PubMed ID: 25871590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chiral high performance liquid chromatography of drug molecules.
    Mehta AC
    J Clin Pharm Ther; 1990 Oct; 15(5):313-23. PubMed ID: 2289933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of biological matrices during the analysis of chiral drugs by liquid chromatography.
    Misl'anová C; Hutta M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Nov; 797(1-2):91-109. PubMed ID: 14630145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated optimization of mass spectrometric parameters in 'Tune' mode for impure analytes in dirty samples using gradient high-performance liquid chromatography.
    Rogatsky E; Stein D
    Rapid Commun Mass Spectrom; 2005; 19(24):3759-60. PubMed ID: 16308844
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of generic chiral liquid chromatography screens for pharmaceutical analysis.
    Andersson ME; Aslan D; Clarke A; Roeraade J; Hagman G
    J Chromatogr A; 2003 Jul; 1005(1-2):83-101. PubMed ID: 12924784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of a column selection system and DryLab software for high-performance liquid chromatography method development.
    Krisko RM; McLaughlin K; Koenigbauer MJ; Lunte CE
    J Chromatogr A; 2006 Jul; 1122(1-2):186-93. PubMed ID: 16712861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical issues in chiral drug analysis in biological fluids by high-performance liquid chromatography.
    Ducharme J; Fernandez C; Gimenez F; Farinotti R
    J Chromatogr B Biomed Appl; 1996 Nov; 686(1):65-75. PubMed ID: 8953193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPTLC methods to assay active ingredients in pharmaceutical formulations: a review of the method development and validation steps.
    Shewiyo DH; Kaale E; Risha PG; Dejaegher B; Smeyers-Verbeke J; Vander Heyden Y
    J Pharm Biomed Anal; 2012 Jul; 66():11-23. PubMed ID: 22494517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical derivatization in LC-MS bioanalysis: current & future challenges.
    Niwa M; Watanabe M; Watanabe N
    Bioanalysis; 2015 Oct; 7(19):2443-9. PubMed ID: 26466805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.